康方生物回应明星双抗数据争议

界面
28 Apr

图片来源:视觉中国界面新闻记者 |陈杨界面新闻编辑 |谢欣康方生物更新明星产品依沃西单抗临床数据带崩合作方股价后,4月28日开盘,公司股价也随之跳水,截至上午收盘报86.85港元/股,大跌12.18%,当下市值779.54亿元,相较上一个交易日收盘市值蒸发超百亿港元。同日上午,康方生物召开业务沟通会,公司创始人、董事长夏瑜回应了关于依沃西单抗HARMONi-2研究初步总生存期(OS)数据的讨论,称...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10